NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

DCTH

Delcath Systems Inc

Jul 11 • 04:00PM ET

11.34

Dollar change -1.21
Percentage change -9.64	%

Healthcare • Medical Devices • USA • NASD

Peers: MNOV CRMD BLRX PSTV HOOK CYCN AVGR SCPH TTOO

| Held by: VTI IWM VXF DWAS IWO SURI XHE IWC VFMO ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	10.03%	Shs Outstand	33.44M	Perf Week	-10.64%
Market Cap	394.93M	Forward P/E	17.96	EPS next Y	0.63	Insider Trans	0.00%	Shs Float	31.33M	Perf Month	-30.04%
Enterprise Value	337.05M	PEG	-	EPS next Q	0.03	Inst Own	40.76%	Short Float	5.09%	Perf Quarter	-0.61%
Income	-14.21M	P/S	7.33	EPS this Y	103.69%	Inst Trans	28.47%	Short Ratio	2.69	Perf Half Y	-7.80%
Sales	53.85M	P/B	4.73	EPS next Y	1741.65%	ROA	-23.02%	Short Interest	1.59M	Perf YTD	-5.81%
Book/sh	2.40	P/C	6.71	EPS next 5Y	-	ROE	-29.95%	52W High	18.23 -37.79%	Perf Year	38.97%
Cash/sh	1.69	P/FCF	-	EPS past 3/5Y	36.35% 69.36%	ROIC	-17.51%	52W Low	7.17 58.16%	Perf 3Y	195.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	118.74% 88.10%	Gross Margin	84.90%	Volatility	5.40% 4.82%	Perf 5Y	19.49%
Dividend TTM	-	EV/Sales	6.26	EPS Y/Y TTM	81.29%	Oper. Margin	-2.77%	ATR (14)	0.70	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	14.61	Sales Y/Y TTM	1068.87%	Profit Margin	-26.38%	RSI (14)	27.61	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.95	EPS Q/Q	106.07%	SMA20	-16.06%	Beta	0.84	Target Price	24.29
Payout	-	Debt/Eq	0.01	Sales Q/Q	530.26%	SMA50	-22.45%	Rel Volume	2.46	Prev Close	12.55
Employees	96	LT Debt/Eq	0.01	Earnings	May 08 BMO	SMA200	-10.84%	Avg Volume	591.96K	Price	11.34
IPO	Oct 23, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.19% 18.32%	Trades		Volume	1,456,558	Change	-9.64%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Initiated	Craig Hallum	Buy	$18
May-14-24	Initiated	Stephens	Overweight	$25
Jul-26-22	Resumed	Canaccord Genuity	Buy	$17
Dec-10-21	Initiated	H.C. Wainwright	Buy	$25
Mar-09-21	Initiated	Canaccord Genuity	Buy	$24
Jan-05-21	Initiated	BTIG Research	Buy	$23
Jun-01-20	Initiated	Laidlaw	Buy	$19

Jun-04-25 12:00PM	Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know (Zacks)
09:40AM	Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? (Zacks)
May-28-25 09:55AM	Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks)
08:50AM	Here's Why Momentum in Delcath Systems (DCTH) Should Keep going (Zacks)
May-22-25 07:00AM	Delcath Systems Issues Full Year 2025 Guidance (Business Wire) -6.32%
04:30PM	Loading…
May-15-25 04:30PM	Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference (Business Wire) +6.54%
May-09-25 05:30PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
03:15AM	Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-25 08:45AM	Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates (Zacks) +23.64%
07:30AM	Delcath Systems Reports First Quarter 2025 Results and Business Highlights (Business Wire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
02:21PM	Delcath Systems Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 07:10AM	Waters (WAT) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer (Business Wire)
Apr-27-25 09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
04:01PM	Loading…
Apr-24-25 04:01PM	Delcath Systems to Host First Quarter 2025 Earnings Call (Business Wire)
Apr-10-25 09:03AM	Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? (Zacks) -7.71%
Apr-09-25 05:00PM	Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma (Business Wire) +9.82%
Apr-02-25 11:49AM	Hospitals Experience FOMO In Adopting Delcath's PHP Treatment (Seeking Alpha)
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
10:46AM	Jim Cramer Blesses Delcath Systems (DCTH): 'You're Not Early, But It's a Win' (InsiderMonkey)
Mar-26-25 09:55AM	Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? (Zacks) -6.52%
Mar-24-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Mar-19-25 09:40AM	Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-06-25 08:00AM	Delcath Systems Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 08:30AM	Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call (Business Wire)
Feb-14-25 08:30AM	Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma (Business Wire)
Jan-31-25 07:00AM	Biotech walks a 'tightrope' amid unclear funding, regulations (Yahoo Finance Video)
Jan-28-25 04:01PM	Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
02:31PM	Loading…
Jan-15-25 02:31PM	Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-13-25 08:00AM	Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +11.41%
Jan-03-25 04:01PM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-30-24 08:00AM	Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises (Business Wire)
Dec-02-24 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire) +6.40%
Nov-09-24 04:00PM	Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-08-24 08:00AM	Delcath Systems Reports Third Quarter 2024 Results and Business Highlights (Business Wire)
Nov-01-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-24 08:30AM	Delcath Systems to Host Third Quarter 2024 Earnings Call (Business Wire)
Oct-17-24 08:30AM	Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results (Business Wire) +7.57%
Sep-20-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-16-24 08:30AM	Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups (Business Wire)
Aug-28-24 04:01PM	Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients (Business Wire)
04:01PM	Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-27-24 08:30AM	Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients (Business Wire) +15.57%
Aug-26-24 04:01PM	Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors (Business Wire) +13.86%
Aug-20-24 08:30AM	Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress (Business Wire)
Aug-12-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-05-24 08:59PM	DCTH Stock Earnings: Delcath Systems Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:01PM	Delcath Systems Reports Second Quarter 2024 Results and Business Highlights (Business Wire)
08:30AM	Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT (Business Wire)
Jul-30-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Jul-22-24 04:01PM	Delcath Systems to Host Second Quarter 2024 Earnings Call (Business Wire)
Jul-15-24 12:00PM	Delcath Systems, Inc. (DCTH) is a Great Momentum Stock: Should You Buy? (Zacks)
Jun-14-24 08:50AM	Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength (Zacks)
Jun-03-24 09:55AM	Does Delcath Systems (DCTH) Have the Potential to Rally 197.87% as Wall Street Analysts Expect? (Zacks)
May-28-24 09:30AM	Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors (Business Wire) -5.53%
May-17-24 09:55AM	Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks) +8.76%
May-15-24 08:50AM	What Makes Delcath Systems (DCTH) a Good Fit for 'Trend Investing' (Zacks)
03:02AM	Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ... (GuruFocus.com)
May-14-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +30.93%
07:30AM	Delcath Systems Reports First Quarter 2024 Results and Business Highlights (PR Newswire)
May-07-24 08:30AM	Delcath Systems to Host First Quarter 2024 Earnings Call (PR Newswire)
May-06-24 09:00AM	Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT (PR Newswire)
May-03-24 05:15PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-23-24 09:55AM	How Much Upside is Left in Delcath Systems (DCTH)? Wall Street Analysts Think 244.83% (Zacks)
Apr-05-24 09:55AM	Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect? (Zacks)
Apr-04-24 08:35AM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-02-24 12:00PM	Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-27-24 11:50AM	Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript (Insider Monkey) +10.41%
Mar-26-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
09:12AM	Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements (GuruFocus.com)
08:40AM	Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (PR Newswire)
Mar-22-24 02:43PM	Hedge Fund and Insider Trading News: David Tepper, Ken Griffin, Starboard Value, ExodusPoint Capital, Elliott Management, Three Arrows Capital, Delcath Systems Inc (DCTH), Dell Technologies Inc (DELL), and More (Insider Monkey)
Mar-20-24 08:15AM	Delcath Systems Closes $7 Million Private Placement (PR Newswire)
Mar-19-24 09:00AM	Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call (PR Newswire)
Mar-18-24 05:20PM	Delcath Systems Appoints Martha S. Rook as Chief Operating Officer (PR Newswire) +5.29%
Mar-15-24 08:20AM	Delcath Systems Announces $7 Million Private Placement (PR Newswire) +6.72%
Mar-08-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
09:00AM	Delcath Systems to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-22-24 05:00PM	Delcath Systems Announces Healthcare Setting Locator for HEPZATO KIT (melphalan/Hepatic Delivery System) (PR Newswire)
Feb-16-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jan-31-24 08:00AM	Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO (melphalan/Hepatic Delivery System) Effective April 1, 2024 (PR Newswire) +7.88%
Jan-23-24 08:00AM	Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference (PR Newswire)
Jan-16-24 08:00AM	Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT (PR Newswire)
Jan-12-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Dec-15-23 01:02PM	Insider Buying: Chief Medical Officer Vojo Vukovic Acquires 40,000 Shares of Delcath Systems ... (GuruFocus.com)
Dec-07-23 09:00AM	Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research (PR Newswire)
Nov-15-23 05:00PM	Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Nov-13-23 04:05PM	Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update (PR Newswire) -24.50%
Nov-06-23 04:30PM	Delcath Systems to Host Third Quarter 2023 Results Call (PR Newswire)
Oct-16-23 08:30AM	Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers (PR Newswire) +6.07%
Oct-10-23 08:30AM	Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference (PR Newswire)
Oct-03-23 08:30AM	Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023 (PR Newswire)
Sep-27-23 04:05PM	Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Sep-14-23 09:59AM	These 2 Strong Buy Penny Stocks Could Soar to $17 (Or Higher), Say Analysts (TipRanks)
Sep-11-23 08:00AM	A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting (PR Newswire)
Sep-05-23 04:00PM	Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023 (PR Newswire)
Sep-01-23 02:07PM	Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT (PR Newswire) +5.88%

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vukovic Vojo	CHIEF MEDICAL OFFICER	Jun 12 '25	Option Exercise	4.78	42,000	200,760	168,882	Jun 13 05:22 PM
MICHEL GERARD J	CHIEF EXECUTIVE OFFICER	Oct 22 '24	Option Exercise	6.00	16,666	99,996	319,334	Oct 23 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DCTH

Delcath Systems Inc

Upgrade your FINVIZ experience